Established in 2011, MicroTech Medical is located in the Hangzhou Future Sci-Tech City, which is the leading venture technology park in Hangzhou. Shortly after, the US R&D center was established in California’s Silicon Valley.
MicroTech’s management and technical teams were recruited from all over the world, with the majority of the group having post-secondary, graduate and/or post-graduate university degrees as well as extensive experience in medical technology.
MicroTech’s certifications include regulatory approvals for CE and CFDA, as well as product conformity to ISO 15197:2015 (BGMS products) and IEC 60601-2-24 (pump therapy products). In 2013, the government designated MicroTech as Lead Diabetes Research Center in Zhejiang Province.
MicroTech Medical is devoted to innovation in chronic disease management, and strives to bring to market healthcare products globally. The company’s portfolio includes therapy products such as the Equil Patch Insulin Pump and diagnostic products such as the AiDEX Continuous Glucose Monitoring System (CGMS), multiple lines of Blood Glucose Monitoring Systems (BGMS), and POCT products.
With the help this line of products, MicroTech Medical continues to allow more freedom, flexibility, and choice to those who are limited by chronic disease.
A private equity fund focusing on investments in internet, e-commerce, consumer retail etc.
World's leading mobile transportation platform.
We are software development company with expertise on customized portals , BI tool, and App s
A global innovation-driven pharmaceutical company.
BEAMSTART is a hub for everything Startups, Entrepreneurship, and Innovation. Connect with a global community of people, and stay updated with the latest news, events, and opportunities.
Connect with the BEAMSTART Entrepreneurship Community from the palm of your hands. Connect with CEOs/Founders, Investors, Business Leaders, and Professionals. Download below to instantly form partnerships and discover opportunities: